Compare Mutual Funds
Pros | Beats FD returns for both 3Y & 5Y duration. | Larger AUM within category. Beats FD returns for both 3Y & 5Y duration. | ||
Cons | 5Y returns in the bottom 25% of the category. 3Y returns in the bottom 25% of the category. | 5Y returns in the bottom 25% of the category. 3Y returns in the bottom 25% of the category. |
INDMoney rank | 5/9 | 9/9 | ||
Category | Equity, Sector - Healthcare | Equity, Sector - Healthcare | ||
Fund Age | 7 Years 3 Months | 13 Years 11 Months | ||
Fund AUM | ₹1103 Cr | ₹9479 Cr | ||
Min Investment |
|
| ||
Expense Ratio | 1.02% | 0.99% | ||
Exit Load | 1% | 1% | ||
Benchmark Index | BSE Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 40 | 38 | ||
Top 5 Holdings |
|
| ||
No of Sectors | 2 | 1 | ||
Top 3 Sectors |
| Health (100%) | ||
Equity % | 97.61% | 97.32% | ||
Debt % | - | - | ||
P/E | 40.73 | 39.2 | ||
P/B | 6.33 | 5.82 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | 0.07% | 0.02% | ||
3-Month Return | 6.87% | 4.21% | ||
6-Month Return | 19.65% | 14.97% | ||
1-Year Return | 19.96% | 13.71% | ||
3-Year Return | 22.27% | 19.7% | ||
5-Year Return | 14.65% | 14.01% |
Sharpe | 1.04 | 0.89 | ||
Alpha | 1.17 | -1.21 | ||
Beta | 0.91 | 0.88 | ||
Standard Deviation | 15.3 | 14.77 | ||
Information Ratio | -0.06 | -0.88 |
Description | Aditya Birla Sun Life Pharma & Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run. | Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Dhaval Shah | Sailesh Raj Bhan, Kinjal Desai, Amber Singhania |

